ReNeuron Group plc
RNUGF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $17 | $17 |
| - Cash | $5 | $6 | $9 | $10 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | -$1 | -$2 | $8 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 70.7% | -79% | 27% | – |
| Gross Profit | -$2 | -$1 | $0 | $0 |
| % Margin | -1,286.6% | -1,505.4% | 69.9% | 57.1% |
| EBITDA | -$3 | -$3 | -$2 | -$2 |
| % Margin | -2,051% | -2,993.5% | -457.8% | -704.6% |
| Net Income | -$3 | -$2 | -$3 | -$4 |
| % Margin | -1,809.6% | -2,426.1% | -725.1% | -1,291.3% |
| EPS Diluted | -0.05 | -0.039 | -0.056 | -0.078 |
| % Growth | -27.4% | 29.9% | 28.8% | – |
| Operating Cash Flow | -$2 | -$3 | -$4 | -$3 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$3 | -$4 | -$3 |